Brian Levy
About
In The Last Decade
Brian Levy
68 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 133
- Ophthalmology 1.1k
- Radiology, Nuclear Medicine and Imaging 738
- Endocrinology, Diabetes and Metabolism 487
- Public Health, Environmental and Occupational Health 457
- Epidemiology 421
Countries citing papers authored by Brian Levy
This map shows the geographic impact of Brian Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Levy more than expected).
Fields of papers citing papers by Brian Levy
This network shows the impact of papers produced by Brian Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Levy. The network helps show where Brian Levy may publish in the future.
Co-authorship network of co-authors of Brian Levy
This figure shows the co-authorship network connecting the top 25 collaborators of Brian Levy. A scholar is included among the top collaborators of Brian Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Levy. Brian Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 13 | |
| 5 | 1 | |
| 6 | Evaluation of AR-13324, a novel dual mechanism agent, in lowering of IOP in glaucoma and ocular hypertension | 8 |
| 7 | Ocular hypotensive efficacy and safety of a fixed dose combination of AR-12286 (a Rho Kinase Inhibitor) and travoprost | 2 |
| 8 | Effects of DNB-001 - A Novel Ion Channel Modulator - On Intraocular Pressure in Glaucomatous Monkey Eyes | 1 |
| 9 | 6 | |
| 10 | Fluocinolone Acetonide Intravitreal Implant to Treat Posterior Segment Uveitis: 3–Year Results of a Multi–Center Clinical Trial | 4 |
| 11 | Fluocinolone Acetonide Intravitreal Implant to Treat Diabetic Macular Edema: 2–year Results of a Multi–Center Clinical Trial | 23 |
| 12 | Fluocinolone Acetonide Intravitreal Implant to Treat Posterior Uveitis: 2–year Results of a Multi–Center Clinical Trial | 5 |
| 13 | 263 | |
| 14 | 43 | |
| 15 | 3 | |
| 16 | 9 | |
| 17 | 10 | |
| 18 | 15 | |
| 19 | 19 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.